Avenue Therapeutics Inc (NAS:ATXI)
$ 3.345 -0.065 (-1.91%) Market Cap: 3.15 Mil Enterprise Value: -46,000.00 PE Ratio: 0 PB Ratio: 0.70 GF Score: 40/100

Avenue Therapeutics Inc Annual Shareholders Meeting Transcript

Dec 16, 2021 / 02:00PM GMT
Release Date Price: $1075.5 (+5.04%)
Lucy Lu
Avenue Therapeutic, Inc. - President & CEO

Good morning. I am Dr. Lucy Lu, Chief Executive Officer, President, and Directors of Avenue Therapeutics, Inc., and I'll be presiding over today's meeting.

In light of the public health concerns due to COVID-19, we are broadcasting our meeting via live webcast. On behalf of our company, I wanted to welcome you to our 2021 Annual Meeting of Stockholders, which is now called to order. We're very pleased to have each of you in attendance at today's meeting. Let me begin by introducing the other Directors of the company in attendance by means of remote communication.

With us today are Dr. Lindsay Rosenwald, Dr. Jaideep Gogtay, Mr. Neil Herskowitz, Dr. Jay Kranzler, Ms. Elizabeth Ingram -- Elizabeth Garrett Ingram, and Mr. Curtis Oltmans. Also, virtually present today is Mr. Joseph Scheriff of BDO USA, LLP, our independent auditors for the fiscal year ended December 31, 2021, and Mr. Matthew Mamak of Alston & Bird LLP, our legal counsel, who will serve as Secretary and the Inspector of Elections of the meeting.

Our order

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot